(694315, 'HP:0002186', 'Apraxia', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694316, 'HP:0002186', 'Apraxia', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694317, 'HP:0002186', 'Apraxia', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694318, 'HP:0002186', 'Apraxia', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694319, 'HP:0002186', 'Apraxia', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694320, 'HP:0002186', 'Apraxia', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694321, 'HP:0002186', 'Apraxia', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694322, 'HP:0002186', 'Apraxia', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694323, 'HP:0002186', 'Apraxia', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694324, 'HP:0002186', 'Apraxia', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694325, 'HP:0002186', 'Apraxia', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694326, 'HP:0002186', 'Apraxia', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694327, 'HP:0002186', 'Apraxia', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694328, 'HP:0002186', 'Apraxia', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694329, 'HP:0002186', 'Apraxia', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694330, 'HP:0002186', 'Apraxia', 'MP:0002064', 'seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694331, 'HP:0002186', 'Apraxia', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694332, 'HP:0002186', 'Apraxia', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694333, 'HP:0002186', 'Apraxia', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694334, 'HP:0002186', 'Apraxia', 'MP:0003777', 'lip inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694335, 'HP:0002186', 'Apraxia', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694336, 'HP:0002186', 'Apraxia', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694337, 'HP:0002186', 'Apraxia', 'MP:0001837', 'defective assembly of class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694338, 'HP:0002186', 'Apraxia', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694339, 'HP:0002186', 'Apraxia', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694340, 'HP:0002186', 'Apraxia', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694341, 'HP:0002186', 'Apraxia', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694342, 'HP:0002186', 'Apraxia', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694343, 'HP:0002186', 'Apraxia', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694344, 'HP:0002186', 'Apraxia', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694345, 'HP:0002186', 'Apraxia', 'MP:0003218', 'decreased spike-wave discharge type I', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694346, 'HP:0002186', 'Apraxia', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694347, 'HP:0002186', 'Apraxia', 'MP:0004835', 'abnormal miniature endplate potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694348, 'HP:0002186', 'Apraxia', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694349, 'HP:0002186', 'Apraxia', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694350, 'HP:0002186', 'Apraxia', 'MP:0021010', 'impaired synaptic physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694351, 'HP:0002186', 'Apraxia', 'MP:0011397', 'endoneurial edema', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694352, 'HP:0002186', 'Apraxia', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694353, 'HP:0002186', 'Apraxia', 'MP:0002917', 'decreased synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694354, 'HP:0002186', 'Apraxia', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694355, 'HP:0002186', 'Apraxia', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694356, 'HP:0002186', 'Apraxia', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694357, 'HP:0002186', 'Apraxia', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694358, 'HP:0002186', 'Apraxia', 'MP:0001912', 'increased cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694359, 'HP:0002186', 'Apraxia', 'MP:0012006', 'abnormal hippocampus physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694360, 'HP:0002186', 'Apraxia', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694361, 'HP:0002186', 'Apraxia', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694362, 'HP:0002186', 'Apraxia', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694363, 'HP:0002186', 'Apraxia', 'MP:0001915', 'intracranial hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694364, 'HP:0002186', 'Apraxia', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694365, 'HP:0002186', 'Apraxia', 'MP:0002499', 'chronic inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694366, 'HP:0002186', 'Apraxia', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694367, 'HP:0002186', 'Apraxia', 'MP:0009141', 'increased prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694368, 'HP:0002186', 'Apraxia', 'MP:0030132', 'periodontium inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694369, 'HP:0002186', 'Apraxia', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694370, 'HP:0002186', 'Apraxia', 'MP:0014255', 'increased paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694371, 'HP:0002186', 'Apraxia', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694372, 'HP:0002186', 'Apraxia', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694373, 'HP:0002186', 'Apraxia', 'MP:0003465', 'increased single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694374, 'HP:0002186', 'Apraxia', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694375, 'HP:0002186', 'Apraxia', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694376, 'HP:0002186', 'Apraxia', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694377, 'HP:0002186', 'Apraxia', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694378, 'HP:0002186', 'Apraxia', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694379, 'HP:0002186', 'Apraxia', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694380, 'HP:0002186', 'Apraxia', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694381, 'HP:0002186', 'Apraxia', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694382, 'HP:0002186', 'Apraxia', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694383, 'HP:0002186', 'Apraxia', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694384, 'HP:0002186', 'Apraxia', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694385, 'HP:0002186', 'Apraxia', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694386, 'HP:0002186', 'Apraxia', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694387, 'HP:0002186', 'Apraxia', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694388, 'HP:0002186', 'Apraxia', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694389, 'HP:0002186', 'Apraxia', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694390, 'HP:0002186', 'Apraxia', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694391, 'HP:0002186', 'Apraxia', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694392, 'HP:0002186', 'Apraxia', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694393, 'HP:0002186', 'Apraxia', 'MP:0014120', 'focal seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694394, 'HP:0002186', 'Apraxia', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694395, 'HP:0002186', 'Apraxia', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694396, 'HP:0002186', 'Apraxia', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694397, 'HP:0002186', 'Apraxia', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694398, 'HP:0002186', 'Apraxia', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694399, 'HP:0002186', 'Apraxia', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694400, 'HP:0002186', 'Apraxia', 'MP:0005043', 'defective assembly of class II molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694401, 'HP:0002186', 'Apraxia', 'MP:0006060', 'increased cerebral infarct size', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694402, 'HP:0002186', 'Apraxia', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694403, 'HP:0002186', 'Apraxia', 'MP:0002826', 'tonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694404, 'HP:0002186', 'Apraxia', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694405, 'HP:0002186', 'Apraxia', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694406, 'HP:0002186', 'Apraxia', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694407, 'HP:0002186', 'Apraxia', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694408, 'HP:0002186', 'Apraxia', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694409, 'HP:0002186', 'Apraxia', 'MP:0004811', 'abnormal neuron physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694410, 'HP:0002186', 'Apraxia', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694411, 'HP:0002186', 'Apraxia', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694412, 'HP:0002186', 'Apraxia', 'MP:0002723', 'abnormal immune serum protein physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694413, 'HP:0002186', 'Apraxia', 'MP:0002498', 'abnormal acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694414, 'HP:0002186', 'Apraxia', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694415, 'HP:0002186', 'Apraxia', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694416, 'HP:0002186', 'Apraxia', 'MP:0000951', 'sporadic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694417, 'HP:0002186', 'Apraxia', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694418, 'HP:0002186', 'Apraxia', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694419, 'HP:0002186', 'Apraxia', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694420, 'HP:0002186', 'Apraxia', 'MP:0003464', 'abnormal single cell response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694421, 'HP:0002186', 'Apraxia', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694422, 'HP:0002186', 'Apraxia', 'MP:0012503', 'increased midbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694423, 'HP:0002186', 'Apraxia', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694424, 'HP:0002186', 'Apraxia', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694425, 'HP:0002186', 'Apraxia', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694426, 'HP:0002186', 'Apraxia', 'MP:0002634', 'abnormal sensorimotor gating', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694427, 'HP:0002186', 'Apraxia', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694428, 'HP:0002186', 'Apraxia', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694429, 'HP:0002186', 'Apraxia', 'MP:0001845', 'abnormal inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694430, 'HP:0002186', 'Apraxia', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694431, 'HP:0002186', 'Apraxia', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694432, 'HP:0002186', 'Apraxia', 'MP:0014253', 'decreased paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694433, 'HP:0002186', 'Apraxia', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694434, 'HP:0002186', 'Apraxia', 'MP:0014256', 'decreased paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694435, 'HP:0002186', 'Apraxia', 'MP:0001917', 'intraventricular hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694436, 'HP:0002186', 'Apraxia', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694437, 'HP:0002186', 'Apraxia', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694438, 'HP:0002186', 'Apraxia', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694439, 'HP:0002186', 'Apraxia', 'MP:0002419', 'abnormal innate immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694440, 'HP:0002186', 'Apraxia', 'MP:0003490', 'decreased channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694441, 'HP:0002186', 'Apraxia', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694442, 'HP:0002186', 'Apraxia', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694443, 'HP:0002186', 'Apraxia', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694444, 'HP:0002186', 'Apraxia', 'MP:0001790', 'abnormal immune system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694445, 'HP:0002186', 'Apraxia', 'MP:0006058', 'decreased cerebral infarct size', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694446, 'HP:0002186', 'Apraxia', 'MP:0003216', 'absence seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694447, 'HP:0002186', 'Apraxia', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694448, 'HP:0002186', 'Apraxia', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694449, 'HP:0002186', 'Apraxia', 'MP:0020154', 'impaired humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694450, 'HP:0002186', 'Apraxia', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694451, 'HP:0002186', 'Apraxia', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694452, 'HP:0002186', 'Apraxia', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694453, 'HP:0002186', 'Apraxia', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694454, 'HP:0002186', 'Apraxia', 'MP:0003489', 'increased channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694455, 'HP:0002186', 'Apraxia', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694456, 'HP:0002186', 'Apraxia', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694457, 'HP:0002186', 'Apraxia', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694458, 'HP:0002186', 'Apraxia', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694459, 'HP:0002186', 'Apraxia', 'MP:0003889', 'enhanced sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694460, 'HP:0002186', 'Apraxia', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694461, 'HP:0002186', 'Apraxia', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694462, 'HP:0002186', 'Apraxia', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694463, 'HP:0002186', 'Apraxia', 'MP:0020002', 'increased response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694464, 'HP:0002186', 'Apraxia', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694465, 'HP:0002186', 'Apraxia', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694466, 'HP:0002186', 'Apraxia', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694467, 'HP:0002186', 'Apraxia', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694468, 'HP:0002186', 'Apraxia', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694469, 'HP:0002186', 'Apraxia', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694470, 'HP:0002186', 'Apraxia', 'MP:0009358', 'environmentally induced seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694471, 'HP:0002186', 'Apraxia', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694472, 'HP:0002186', 'Apraxia', 'MP:0003486', 'abnormal channel response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694473, 'HP:0002186', 'Apraxia', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694474, 'HP:0002186', 'Apraxia', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694475, 'HP:0002186', 'Apraxia', 'MP:0003471', 'abnormal summary potential threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694476, 'HP:0002186', 'Apraxia', 'MP:0005000', 'abnormal immune tolerance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694477, 'HP:0002186', 'Apraxia', 'MP:0030153', 'dental pulp inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694478, 'HP:0002186', 'Apraxia', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694479, 'HP:0002186', 'Apraxia', 'MP:0003467', 'abnormal single cell response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694480, 'HP:0002186', 'Apraxia', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694481, 'HP:0002186', 'Apraxia', 'MP:0000947', 'convulsive seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694482, 'HP:0002186', 'Apraxia', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694483, 'HP:0002186', 'Apraxia', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694484, 'HP:0002186', 'Apraxia', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694485, 'HP:0002186', 'Apraxia', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694486, 'HP:0002186', 'Apraxia', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694487, 'HP:0002186', 'Apraxia', 'MP:0003762', 'abnormal immune organ physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694488, 'HP:0002186', 'Apraxia', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694489, 'HP:0002186', 'Apraxia', 'MP:0008814', 'decreased nerve conduction velocity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694490, 'HP:0002186', 'Apraxia', 'MP:0004752', 'decreased length of allograft survival', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694491, 'HP:0002186', 'Apraxia', 'MP:0021015', 'increased tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694492, 'HP:0002186', 'Apraxia', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694493, 'HP:0002186', 'Apraxia', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694494, 'HP:0002186', 'Apraxia', 'MP:0001876', 'decreased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694495, 'HP:0002186', 'Apraxia', 'MP:0004513', 'avnosmia', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694496, 'HP:0002186', 'Apraxia', 'MP:0003475', 'increased summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694497, 'HP:0002186', 'Apraxia', 'MP:0020155', 'enhanced humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694498, 'HP:0002186', 'Apraxia', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694499, 'HP:0002186', 'Apraxia', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694500, 'HP:0002186', 'Apraxia', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694501, 'HP:0002186', 'Apraxia', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694502, 'HP:0002186', 'Apraxia', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694503, 'HP:0002186', 'Apraxia', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694504, 'HP:0002186', 'Apraxia', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694505, 'HP:0002186', 'Apraxia', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694506, 'HP:0002186', 'Apraxia', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694507, 'HP:0002186', 'Apraxia', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694508, 'HP:0002186', 'Apraxia', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694509, 'HP:0002186', 'Apraxia', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694510, 'HP:0002186', 'Apraxia', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694511, 'HP:0002186', 'Apraxia', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694512, 'HP:0002186', 'Apraxia', 'MP:0001793', 'abnormal susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694513, 'HP:0002186', 'Apraxia', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694514, 'HP:0002186', 'Apraxia', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694515, 'HP:0002186', 'Apraxia', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694516, 'HP:0002186', 'Apraxia', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694517, 'HP:0002186', 'Apraxia', 'MP:0020000', 'abnormal response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694518, 'HP:0002186', 'Apraxia', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694519, 'HP:0002186', 'Apraxia', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694520, 'HP:0002186', 'Apraxia', 'MP:0002914', 'abnormal endplate potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694521, 'HP:0002186', 'Apraxia', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694522, 'HP:0002186', 'Apraxia', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694523, 'HP:0002186', 'Apraxia', 'MP:0003990', 'decreased neurotransmitter release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694524, 'HP:0002186', 'Apraxia', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694525, 'HP:0002186', 'Apraxia', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694526, 'HP:0002186', 'Apraxia', 'MP:0002922', 'decreased post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694527, 'HP:0002186', 'Apraxia', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694528, 'HP:0002186', 'Apraxia', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694529, 'HP:0002186', 'Apraxia', 'MP:0012011', 'febrile seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694530, 'HP:0002186', 'Apraxia', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694531, 'HP:0002186', 'Apraxia', 'MP:0003202', 'abnormal neuron apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694532, 'HP:0002186', 'Apraxia', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694533, 'HP:0002186', 'Apraxia', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694534, 'HP:0002186', 'Apraxia', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694535, 'HP:0002186', 'Apraxia', 'MP:0005001', 'abnormal clonal deletion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694536, 'HP:0002186', 'Apraxia', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694537, 'HP:0002186', 'Apraxia', 'MP:0003633', 'abnormal nervous system physiology', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694538, 'HP:0002186', 'Apraxia', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694539, 'HP:0002186', 'Apraxia', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694540, 'HP:0002186', 'Apraxia', 'MP:0001916', 'intracerebral hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694541, 'HP:0002186', 'Apraxia', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694542, 'HP:0002186', 'Apraxia', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694543, 'HP:0002186', 'Apraxia', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694544, 'HP:0002186', 'Apraxia', 'MP:0003220', 'decreased spike-wave discharge type II', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694545, 'HP:0002186', 'Apraxia', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694546, 'HP:0002186', 'Apraxia', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694547, 'HP:0002186', 'Apraxia', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694548, 'HP:0002186', 'Apraxia', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694549, 'HP:0002186', 'Apraxia', 'MP:0006051', 'brainstem hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694550, 'HP:0002186', 'Apraxia', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694551, 'HP:0002186', 'Apraxia', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694552, 'HP:0002186', 'Apraxia', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694553, 'HP:0002186', 'Apraxia', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694554, 'HP:0002186', 'Apraxia', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694555, 'HP:0002186', 'Apraxia', 'MP:0013182', 'increased spinal cord apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694556, 'HP:0002186', 'Apraxia', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694557, 'HP:0002186', 'Apraxia', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694558, 'HP:0002186', 'Apraxia', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694559, 'HP:0002186', 'Apraxia', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694560, 'HP:0002186', 'Apraxia', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694561, 'HP:0002186', 'Apraxia', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694562, 'HP:0002186', 'Apraxia', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694563, 'HP:0002186', 'Apraxia', 'MP:0004495', 'decreased synaptic glutamate release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694564, 'HP:0002186', 'Apraxia', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694565, 'HP:0002186', 'Apraxia', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694566, 'HP:0002186', 'Apraxia', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694567, 'HP:0002186', 'Apraxia', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694568, 'HP:0002186', 'Apraxia', 'MP:0006054', 'spinal hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694569, 'HP:0002186', 'Apraxia', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694570, 'HP:0002186', 'Apraxia', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694571, 'HP:0002186', 'Apraxia', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694572, 'HP:0002186', 'Apraxia', 'MP:0008744', 'abnormal B cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694573, 'HP:0002186', 'Apraxia', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694574, 'HP:0002186', 'Apraxia', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694575, 'HP:0002186', 'Apraxia', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694576, 'HP:0002186', 'Apraxia', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694577, 'HP:0002186', 'Apraxia', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694578, 'HP:0002186', 'Apraxia', 'MP:0010653', 'abnormal Wallerian degeneration', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694579, 'HP:0002186', 'Apraxia', 'MP:0001846', 'increased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694580, 'HP:0002186', 'Apraxia', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694581, 'HP:0002186', 'Apraxia', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694582, 'HP:0002186', 'Apraxia', 'MP:0003217', 'increased spike-wave discharge type I', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694583, 'HP:0002186', 'Apraxia', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694584, 'HP:0002186', 'Apraxia', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694585, 'HP:0002186', 'Apraxia', 'MP:0003487', 'increased channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694586, 'HP:0002186', 'Apraxia', 'MP:0000948', 'nonconvulsive seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694587, 'HP:0002186', 'Apraxia', 'MP:0009967', 'abnormal neuron proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694588, 'HP:0002186', 'Apraxia', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694589, 'HP:0002186', 'Apraxia', 'MP:0001900', 'impaired synaptic plasticity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694590, 'HP:0002186', 'Apraxia', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694591, 'HP:0002186', 'Apraxia', 'MP:0000921', 'demyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694592, 'HP:0002186', 'Apraxia', 'MP:0010746', 'abnormal pre-Botzinger complex physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694593, 'HP:0002186', 'Apraxia', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694594, 'HP:0002186', 'Apraxia', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694595, 'HP:0002186', 'Apraxia', 'MP:0003485', 'abnormal channel response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694596, 'HP:0002186', 'Apraxia', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694597, 'HP:0002186', 'Apraxia', 'MP:0004768', 'abnormal axonal transport', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694598, 'HP:0002186', 'Apraxia', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694599, 'HP:0002186', 'Apraxia', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694600, 'HP:0002186', 'Apraxia', 'MP:0005671', 'abnormal response to transplant', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694601, 'HP:0002186', 'Apraxia', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694602, 'HP:0002186', 'Apraxia', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694603, 'HP:0002186', 'Apraxia', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694604, 'HP:0002186', 'Apraxia', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694605, 'HP:0002186', 'Apraxia', 'MP:0003880', 'abnormal central pattern generator function', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694606, 'HP:0002186', 'Apraxia', 'MP:0002471', 'abnormal complement pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694607, 'HP:0002186', 'Apraxia', 'MP:0010050', 'hypermyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694608, 'HP:0002186', 'Apraxia', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694609, 'HP:0002186', 'Apraxia', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694610, 'HP:0002186', 'Apraxia', 'MP:0001499', 'abnormal kindling response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694611, 'HP:0002186', 'Apraxia', 'MP:0003468', 'increased single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694612, 'HP:0002186', 'Apraxia', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694613, 'HP:0002186', 'Apraxia', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694614, 'HP:0002186', 'Apraxia', 'MP:0005005', 'abnormal self tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694615, 'HP:0002186', 'Apraxia', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694616, 'HP:0002186', 'Apraxia', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694617, 'HP:0002186', 'Apraxia', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694618, 'HP:0002186', 'Apraxia', 'MP:0003635', 'abnormal synaptic transmission', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694619, 'HP:0002186', 'Apraxia', 'MP:0001847', 'brain inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694620, 'HP:0002186', 'Apraxia', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694621, 'HP:0002186', 'Apraxia', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694622, 'HP:0002186', 'Apraxia', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694623, 'HP:0002186', 'Apraxia', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694624, 'HP:0002186', 'Apraxia', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694625, 'HP:0002186', 'Apraxia', 'MP:0008722', 'abnormal chemokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694626, 'HP:0002186', 'Apraxia', 'MP:0014254', 'increased paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694627, 'HP:0002186', 'Apraxia', 'MP:0003472', 'increased summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694628, 'HP:0002186', 'Apraxia', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694629, 'HP:0002186', 'Apraxia', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694630, 'HP:0002186', 'Apraxia', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694631, 'HP:0002186', 'Apraxia', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694632, 'HP:0002186', 'Apraxia', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694633, 'HP:0002186', 'Apraxia', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694634, 'HP:0002186', 'Apraxia', 'MP:0003482', 'increased nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694635, 'HP:0002186', 'Apraxia', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694636, 'HP:0002186', 'Apraxia', 'MP:0014178', 'increased brain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694637, 'HP:0002186', 'Apraxia', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694638, 'HP:0002186', 'Apraxia', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694639, 'HP:0002186', 'Apraxia', 'MP:0008555', 'abnormal interferon secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694640, 'HP:0002186', 'Apraxia', 'MP:0005004', 'abnormal lymphocyte anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694641, 'HP:0002186', 'Apraxia', 'MP:0013438', 'dysmyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694642, 'HP:0002186', 'Apraxia', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694643, 'HP:0002186', 'Apraxia', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694644, 'HP:0002186', 'Apraxia', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694645, 'HP:0002186', 'Apraxia', 'MP:0021001', 'impaired neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694646, 'HP:0002186', 'Apraxia', 'MP:0008921', 'increased neurotransmitter release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694647, 'HP:0002186', 'Apraxia', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694648, 'HP:0002186', 'Apraxia', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694649, 'HP:0002186', 'Apraxia', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694650, 'HP:0002186', 'Apraxia', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694651, 'HP:0002186', 'Apraxia', 'MP:0003476', 'decreased summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694652, 'HP:0002186', 'Apraxia', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694653, 'HP:0001489', 'Posterior vitreous detachment', 'MP:0005176', 'eyelids fail to open', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(694654, 'HP:0001489', 'Posterior vitreous detachment', 'MP:0006209', 'calcified intraocular region', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(694655, 'HP:0001489', 'Posterior vitreous detachment', 'MP:0006200', 'vitreous body deposition', 0.4230769230769231, 7.832360208310102, 1.820354596599785, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(694656, 'HP:0001489', 'Posterior vitreous detachment', 'MP:0002697', 'abnormal eye size', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(694657, 'HP:0001489', 'Posterior vitreous detachment', 'MP:0005195', 'abnormal posterior eye segment morphology', 0.40816326530612246, 7.832360208310102, 1.7879825831583462, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(694658, 'HP:0001489', 'Posterior vitreous detachment', 'MP:0006225', 'ocular rupture', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(694659, 'HP:0001489', 'Posterior vitreous detachment', 'MP:0001289', 'persistence of hyaloid vascular system', 0.41509433962264153, 7.832360208310102, 1.803099661237597, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(694660, 'HP:0001489', 'Posterior vitreous detachment', 'MP:0002700', 'increased opacity of vitreous body', 0.4074074074074074, 7.832360208310102, 1.786326276565555, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(694661, 'HP:0001489', 'Posterior vitreous detachment', 'MP:0003381', 'vitreal fibroplasia', 0.4230769230769231, 7.832360208310102, 1.820354596599785, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(694662, 'HP:0001489', 'Posterior vitreous detachment', 'MP:0002699', 'abnormal vitreous body morphology', 0.43137254901960786, 7.832360208310102, 1.8381145742032718, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(694663, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694664, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694665, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0008814', 'decreased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694666, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694667, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003464', 'abnormal single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694668, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694669, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0014120', 'focal seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694670, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694671, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694672, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694673, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0000947', 'convulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694674, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003467', 'abnormal single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694675, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003476', 'decreased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694676, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0012011', 'febrile seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694677, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003469', 'decreased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694678, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003474', 'abnormal summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694679, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0002635', 'reduced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694680, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003463', 'abnormal single cell response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694681, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003472', 'increased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694682, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0012006', 'abnormal hippocampus physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694683, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0011994', 'increased nerve conduction velocity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694684, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694685, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694686, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694687, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0021015', 'increased tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694688, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694689, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694690, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694691, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0005402', 'abnormal action potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694692, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0004994', 'abnormal brain wave pattern', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694693, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0021009', 'abnormal synaptic physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694694, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003475', 'increased summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694695, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0002578', 'impaired ability to fire action potentials', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694696, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003465', 'increased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694697, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0002634', 'abnormal sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694698, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694699, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0005403', 'abnormal nerve conduction', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694700, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694701, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003477', 'abnormal nerve fiber response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694702, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694703, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003473', 'decreased summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694704, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694705, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694706, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694707, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003889', 'enhanced sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694708, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694709, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694710, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003633', 'abnormal nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694711, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003468', 'increased single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694712, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694713, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003470', 'abnormal summary potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694714, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0002064', 'seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694715, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694716, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0006080', 'brain ischemia', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694717, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694718, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003480', 'increased nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694719, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0013806', 'encephalopathy', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694720, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694721, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003880', 'abnormal central pattern generator function', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694722, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694723, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003466', 'decreased single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694724, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003482', 'increased nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694725, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694726, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0000948', 'nonconvulsive seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694727, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694728, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0003471', 'abnormal summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694729, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694730, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0000951', 'sporadic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694731, 'HP:0032746', 'Focal impaired awareness emotional seizure', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(694732, 'HP:0200066', 'Ribbonlike corneal degeneration', 'MP:0031499', 'decreased cornea size', 0.4262295081967213, 11.115294171581601, 2.1766181034382464, 'UPHENO:0020998', 'abnormal cornea morphology'),
(694733, 'HP:0200066', 'Ribbonlike corneal degeneration', 'MP:0020859', 'disorganized corneal epithelium', 0.4166666666666667, 10.417322709031257, 2.0833989365368852, 'UPHENO:0087577', 'abnormal cornea morphology'),
(694734, 'HP:0200066', 'Ribbonlike corneal degeneration', 'MP:0001307', 'fused cornea and lens', 0.40625, 11.115294171581601, 2.12499135461889, 'UPHENO:0020998', 'abnormal cornea morphology'),
(694735, 'HP:0200066', 'Ribbonlike corneal degeneration', 'MP:0020853', 'abnormal corneal epithelium thickness', 0.4098360655737705, 10.417322709031257, 2.0662513285855773, 'UPHENO:0087577', 'abnormal cornea morphology'),
(694736, 'HP:0200066', 'Ribbonlike corneal degeneration', 'MP:0031500', 'increased cornea size', 0.4262295081967213, 11.115294171581601, 2.1766181034382464, 'UPHENO:0020998', 'abnormal cornea morphology'),
(694737, 'HP:0200066', 'Ribbonlike corneal degeneration', 'MP:0012351', 'cornea degeneration', 0.5272727272727272, 15.384754846574829, 2.84815056595957, 'UPHENO:0074000', 'cornea degeneration'),
(694738, 'HP:0200066', 'Ribbonlike corneal degeneration', 'MP:0006209', 'calcified intraocular region', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(694739, 'HP:0200066', 'Ribbonlike corneal degeneration', 'MP:0006225', 'ocular rupture', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(694740, 'HP:0200066', 'Ribbonlike corneal degeneration', 'MP:0031498', 'abnormal cornea size', 0.45614035087719296, 11.115294171581601, 2.2516958461409593, 'UPHENO:0020998', 'abnormal cornea morphology'),
(694741, 'HP:0200066', 'Ribbonlike corneal degeneration', 'MP:0012353', 'bilateral cornea degeneration', 0.5178571428571429, 15.384754846574829, 2.8226060986975887, 'UPHENO:0074000', 'cornea degeneration'),
(694742, 'HP:0200066', 'Ribbonlike corneal degeneration', 'MP:0011961', 'abnormal cornea thickness', 0.43333333333333335, 11.115294171581601, 2.1946816339396533, 'UPHENO:0020998', 'abnormal cornea morphology'),
(694743, 'HP:0200066', 'Ribbonlike corneal degeneration', 'MP:0002697', 'abnormal eye size', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(694744, 'HP:0200066', 'Ribbonlike corneal degeneration', 'MP:0001312', 'abnormal cornea morphology', 0.4074074074074074, 10.417322709031257, 2.060120005488208, 'UPHENO:0087577', 'abnormal cornea morphology'),
(694745, 'HP:0200066', 'Ribbonlike corneal degeneration', 'MP:0031432', 'cornea perforation', 0.45614035087719296, 11.115294171581601, 2.2516958461409593, 'UPHENO:0020998', 'abnormal cornea morphology'),
(694746, 'HP:0200066', 'Ribbonlike corneal degeneration', 'MP:0012352', 'progressive cornea degeneration', 0.5178571428571429, 15.384754846574829, 2.8226060986975887, 'UPHENO:0074000', 'cornea degeneration'),
(694747, 'HP:0200066', 'Ribbonlike corneal degeneration', 'MP:0031176', 'abnormal Descemet membrane thickness', 0.4098360655737705, 10.417322709031257, 2.0662513285855773, 'UPHENO:0087577', 'abnormal cornea morphology'),
(694748, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694749, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694750, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694751, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694752, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694753, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694754, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694755, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694756, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694757, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694758, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694759, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694760, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694761, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694762, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694763, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694764, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694765, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694766, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694767, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694768, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694769, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694770, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694771, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694772, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694773, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694774, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694775, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694776, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694777, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694778, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694779, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694780, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694781, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694782, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694783, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694784, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694785, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694786, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694787, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694788, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694789, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694790, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694791, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694792, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694793, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694794, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694795, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694796, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694797, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694798, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694799, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694800, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694801, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694802, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694803, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694804, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694805, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694806, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694807, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694808, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694809, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694810, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694811, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694812, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694813, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694814, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694815, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694816, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694817, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694818, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694819, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694820, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694821, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694822, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694823, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694824, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694825, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694826, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694827, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694828, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694829, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694830, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694831, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694832, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694833, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694834, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694835, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694836, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694837, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694838, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694839, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694840, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694841, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694842, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694843, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694844, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694845, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694846, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694847, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694848, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694849, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694850, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694851, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694852, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694853, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694854, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694855, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694856, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694857, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694858, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694859, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694860, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694861, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694862, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694863, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694864, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694865, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694866, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694867, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694868, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694869, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694870, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694871, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694872, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694873, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694874, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694875, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694876, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694877, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694878, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694879, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694880, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694881, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694882, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694883, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694884, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694885, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694886, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694887, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694888, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694889, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694890, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694891, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694892, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694893, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694894, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694895, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694896, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694897, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694898, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694899, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694900, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694901, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694902, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694903, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694904, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694905, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694906, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694907, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694908, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694909, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694910, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694911, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694912, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694913, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694914, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694915, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694916, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694917, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694918, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694919, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694920, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694921, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694922, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694923, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694924, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694925, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694926, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694927, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694928, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694929, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694930, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694931, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694932, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694933, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694934, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694935, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694936, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694937, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694938, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694939, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694940, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694941, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694942, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694943, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694944, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694945, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694946, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694947, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694948, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694949, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694950, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694951, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694952, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694953, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694954, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694955, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694956, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694957, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694958, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694959, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694960, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694961, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694962, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694963, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694964, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694965, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694966, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694967, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694968, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694969, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694970, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694971, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694972, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694973, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694974, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694975, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694976, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694977, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694978, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694979, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694980, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694981, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694982, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694983, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694984, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694985, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694986, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694987, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694988, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694989, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694990, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694991, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694992, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694993, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694994, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694995, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(694996, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694997, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694998, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(694999, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695000, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695001, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695002, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695003, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695004, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695005, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695006, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695007, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695008, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695009, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695010, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695011, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695012, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695013, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695014, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695015, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695016, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695017, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695018, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695019, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695020, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695021, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695022, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695023, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695024, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695025, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695026, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695027, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695028, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695029, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695030, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695031, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695032, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695033, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695034, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695035, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695036, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695037, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695038, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695039, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695040, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695041, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695042, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695043, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695044, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695045, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695046, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695047, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695048, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695049, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695050, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695051, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695052, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695053, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695054, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695055, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695056, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695057, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695058, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695059, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695060, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695061, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695062, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695063, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695064, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695065, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695066, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695067, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695068, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695069, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695070, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695071, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695072, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695073, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695074, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695075, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695076, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695077, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695078, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695079, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695080, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695081, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695082, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695083, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695084, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695085, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695086, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695087, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695088, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695089, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695090, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695091, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695092, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695093, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695094, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695095, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695096, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695097, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695098, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695099, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695100, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695101, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695102, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695103, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695104, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695105, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695106, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695107, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695108, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695109, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695110, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695111, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695112, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695113, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695114, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695115, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695116, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695117, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695118, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695119, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695120, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695121, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695122, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695123, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695124, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695125, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695126, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695127, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695128, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695129, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695130, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695131, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695132, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695133, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695134, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695135, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695136, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695137, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695138, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695139, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695140, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695141, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695142, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695143, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695144, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695145, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695146, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695147, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695148, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695149, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695150, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695151, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695152, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695153, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695154, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695155, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695156, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695157, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695158, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695159, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695160, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695161, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695162, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695163, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695164, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695165, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695166, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695167, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695168, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695169, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695170, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695171, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695172, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695173, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695174, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695175, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695176, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695177, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695178, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695179, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695180, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695181, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695182, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695183, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695184, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695185, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695186, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695187, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695188, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695189, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695190, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695191, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695192, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695193, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695194, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695195, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695196, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695197, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695198, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695199, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695200, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695201, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695202, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695203, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695204, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695205, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695206, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695207, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695208, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695209, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695210, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695211, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695212, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695213, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695214, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695215, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695216, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695217, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695218, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695219, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695220, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695221, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695222, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695223, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695224, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695225, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695226, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695227, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695228, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695229, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695230, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695231, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695232, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695233, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695234, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695235, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695236, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695237, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695238, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695239, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695240, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695241, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695242, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695243, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695244, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695245, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695246, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695247, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695248, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695249, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695250, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695251, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695252, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695253, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695254, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695255, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695256, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695257, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695258, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695259, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695260, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695261, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695262, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695263, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695264, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695265, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695266, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695267, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695268, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695269, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695270, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695271, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695272, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695273, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695274, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695275, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695276, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695277, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695278, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695279, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695280, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695281, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695282, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695283, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695284, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695285, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695286, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695287, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695288, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695289, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695290, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695291, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695292, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695293, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695294, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695295, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695296, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695297, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695298, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695299, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695300, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695301, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695302, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695303, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695304, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695305, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695306, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695307, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695308, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695309, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695310, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695311, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695312, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695313, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695314, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695315, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695316, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695317, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695318, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695319, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695320, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695321, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695322, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695323, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695324, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695325, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695326, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695327, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695328, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695329, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695330, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695331, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695332, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695333, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695334, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695335, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695336, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695337, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695338, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695339, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695340, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695341, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695342, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695343, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695344, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695345, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695346, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695347, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695348, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695349, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695350, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695351, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695352, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695353, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695354, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695355, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695356, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695357, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695358, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695359, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695360, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695361, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695362, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695363, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695364, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695365, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695366, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695367, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695368, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695369, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695370, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695371, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695372, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695373, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695374, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695375, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695376, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695377, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695378, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695379, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695380, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695381, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695382, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695383, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695384, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695385, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695386, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695387, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695388, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695389, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695390, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695391, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695392, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695393, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695394, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695395, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695396, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695397, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695398, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695399, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695400, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695401, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695402, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695403, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695404, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695405, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695406, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695407, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695408, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695409, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695410, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695411, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695412, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695413, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695414, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695415, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695416, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695417, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695418, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695419, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695420, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695421, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695422, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695423, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695424, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695425, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695426, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695427, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695428, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695429, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695430, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695431, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695432, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695433, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695434, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695435, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695436, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695437, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695438, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695439, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695440, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695441, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695442, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695443, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695444, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695445, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695446, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695447, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695448, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695449, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695450, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695451, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695452, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695453, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695454, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695455, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695456, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695457, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695458, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695459, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695460, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695461, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695462, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695463, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695464, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695465, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695466, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695467, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695468, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695469, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695470, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695471, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695472, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695473, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695474, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695475, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695476, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695477, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695478, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695479, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695480, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695481, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695482, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695483, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695484, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695485, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695486, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695487, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695488, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695489, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695490, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695491, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695492, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695493, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695494, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695495, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(695496, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695497, 'HP:4000170', 'Anti-platelet antigen antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695498, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0013118', 'swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695499, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0031291', 'pes valgus', 0.4166666666666667, 5.594289979986924, 1.5267462652084285, 'UPHENO:0002830', 'abnormal limb'),
(695500, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0002132', 'abnormal respiratory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695501, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0006280', 'abnormal digit development', 0.43478260869565216, 5.594289979986924, 1.5595832748842438, 'UPHENO:0002830', 'abnormal limb'),
(695502, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695503, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0013069', 'limb wound', 0.4166666666666667, 5.594289979986924, 1.5267462652084285, 'UPHENO:0002830', 'abnormal limb'),
(695504, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0008909', 'supination', 0.4166666666666667, 5.594289979986924, 1.5267462652084285, 'UPHENO:0002830', 'abnormal limb'),
(695505, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0000428', 'abnormal craniofacial morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695506, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0005500', 'abnormal gustatory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695507, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0000550', 'abnormal forelimb morphology', 0.43478260869565216, 5.594289979986924, 1.5595832748842438, 'UPHENO:0002830', 'abnormal limb'),
(695508, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0002160', 'abnormal reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695509, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0004134', 'abnormal chest morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695510, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0003385', 'abnormal body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695511, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695512, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0014134', 'abnormal embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695513, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0002108', 'abnormal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695514, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695515, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0002111', 'abnormal tail morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695516, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695517, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695518, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695519, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0012531', 'delayed limb development', 0.43478260869565216, 5.594289979986924, 1.5595832748842438, 'UPHENO:0002830', 'abnormal limb'),
(695520, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0006281', 'abnormal tail development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695521, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0020973', 'abnormal gland development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695522, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695523, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0003854', 'abnormal forelimb stylopod morphology', 0.4230769230769231, 7.310231061031986, 1.7586330101197245, 'UPHENO:0002880', 'abnormal arm'),
(695524, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0013113', 'greasy tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695525, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0000685', 'abnormal immune system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695526, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0013332', 'peliosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695527, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0000462', 'abnormal digestive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695528, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695529, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0000578', 'ulcerated paws', 0.4166666666666667, 5.594289979986924, 1.5267462652084285, 'UPHENO:0002830', 'abnormal limb'),
(695530, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0008923', 'thoracoschisis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695531, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0003279', 'aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695532, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0010233', 'hairless tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695533, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695534, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0003855', 'abnormal forelimb zeugopod morphology', 0.44, 7.310231061031986, 1.7934608071697786, 'UPHENO:0002880', 'abnormal arm'),
(695535, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0005508', 'abnormal skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695536, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0002163', 'abnormal gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695537, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0006279', 'abnormal limb development', 0.45454545454545453, 5.594289979986924, 1.5946344665195966, 'UPHENO:0002830', 'abnormal limb'),
(695538, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0000556', 'abnormal hindlimb morphology', 0.43478260869565216, 5.594289979986924, 1.5595832748842438, 'UPHENO:0002830', 'abnormal limb'),
(695539, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0002925', 'abnormal cardiovascular development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695540, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695541, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0020982', 'abnormal skin adnexa development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695542, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0013133', 'pale limbs', 0.45454545454545453, 5.594289979986924, 1.5946344665195966, 'UPHENO:0002830', 'abnormal limb'),
(695543, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0031310', 'abnormal cyst', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695544, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0005499', 'abnormal olfactory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695545, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0011685', 'abnormal limb paddle morphology', 0.4166666666666667, 5.594289979986924, 1.5267462652084285, 'UPHENO:0002830', 'abnormal limb'),
(695546, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0000572', 'abnormal autopod morphology', 0.43478260869565216, 5.594289979986924, 1.5595832748842438, 'UPHENO:0002830', 'abnormal limb'),
(695547, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0002109', 'abnormal limb morphology', 0.47619047619047616, 5.594289979986924, 1.632160411699041, 'UPHENO:0002830', 'abnormal limb'),
(695548, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695549, 'HP:0009142', 'Duplication of bones involving the upper extremities', 'MP:0003632', 'abnormal nervous system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695550, 'HP:5200044', 'Reduced attention regulation', 'MP:0003467', 'abnormal single cell response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695551, 'HP:5200044', 'Reduced attention regulation', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695552, 'HP:5200044', 'Reduced attention regulation', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695553, 'HP:5200044', 'Reduced attention regulation', 'MP:0003474', 'abnormal summary potential intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695554, 'HP:5200044', 'Reduced attention regulation', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695555, 'HP:5200044', 'Reduced attention regulation', 'MP:0003216', 'absence seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695556, 'HP:5200044', 'Reduced attention regulation', 'MP:0002064', 'seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695557, 'HP:5200044', 'Reduced attention regulation', 'MP:0005402', 'abnormal action potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695558, 'HP:5200044', 'Reduced attention regulation', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695559, 'HP:5200044', 'Reduced attention regulation', 'MP:0003996', 'clonic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695560, 'HP:5200044', 'Reduced attention regulation', 'MP:0003475', 'increased summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695561, 'HP:5200044', 'Reduced attention regulation', 'MP:0021009', 'abnormal synaptic physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695562, 'HP:5200044', 'Reduced attention regulation', 'MP:0000951', 'sporadic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695563, 'HP:5200044', 'Reduced attention regulation', 'MP:0002826', 'tonic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695564, 'HP:5200044', 'Reduced attention regulation', 'MP:0004994', 'abnormal brain wave pattern', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695565, 'HP:5200044', 'Reduced attention regulation', 'MP:0020371', 'abnormal glymphatic system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695566, 'HP:5200044', 'Reduced attention regulation', 'MP:0004859', 'abnormal synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695567, 'HP:5200044', 'Reduced attention regulation', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695568, 'HP:5200044', 'Reduced attention regulation', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695569, 'HP:5200044', 'Reduced attention regulation', 'MP:0008814', 'decreased nerve conduction velocity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695570, 'HP:5200044', 'Reduced attention regulation', 'MP:0003465', 'increased single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695571, 'HP:5200044', 'Reduced attention regulation', 'MP:0003889', 'enhanced sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695572, 'HP:5200044', 'Reduced attention regulation', 'MP:0000948', 'nonconvulsive seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695573, 'HP:5200044', 'Reduced attention regulation', 'MP:0003880', 'abnormal central pattern generator function', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695574, 'HP:5200044', 'Reduced attention regulation', 'MP:0000920', 'abnormal myelination', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695575, 'HP:5200044', 'Reduced attention regulation', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695576, 'HP:5200044', 'Reduced attention regulation', 'MP:0003476', 'decreased summary potential intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695577, 'HP:5200044', 'Reduced attention regulation', 'MP:0002578', 'impaired ability to fire action potentials', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695578, 'HP:5200044', 'Reduced attention regulation', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695579, 'HP:5200044', 'Reduced attention regulation', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695580, 'HP:5200044', 'Reduced attention regulation', 'MP:0014120', 'focal seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695581, 'HP:5200044', 'Reduced attention regulation', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695582, 'HP:5200044', 'Reduced attention regulation', 'MP:0003472', 'increased summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695583, 'HP:5200044', 'Reduced attention regulation', 'MP:0003481', 'decreased nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695584, 'HP:5200044', 'Reduced attention regulation', 'MP:0021016', 'decreased tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695585, 'HP:5200044', 'Reduced attention regulation', 'MP:0003483', 'decreased nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695586, 'HP:5200044', 'Reduced attention regulation', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695587, 'HP:5200044', 'Reduced attention regulation', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695588, 'HP:5200044', 'Reduced attention regulation', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695589, 'HP:5200044', 'Reduced attention regulation', 'MP:0011399', 'increased endoneurial fluid pressure', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695590, 'HP:5200044', 'Reduced attention regulation', 'MP:0009358', 'environmentally induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695591, 'HP:5200044', 'Reduced attention regulation', 'MP:0003480', 'increased nerve fiber response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695592, 'HP:5200044', 'Reduced attention regulation', 'MP:0003482', 'increased nerve fiber response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695593, 'HP:5200044', 'Reduced attention regulation', 'MP:0013806', 'encephalopathy', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695594, 'HP:5200044', 'Reduced attention regulation', 'MP:0003468', 'increased single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695595, 'HP:5200044', 'Reduced attention regulation', 'MP:0003471', 'abnormal summary potential threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695596, 'HP:5200044', 'Reduced attention regulation', 'MP:0012006', 'abnormal hippocampus physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695597, 'HP:5200044', 'Reduced attention regulation', 'MP:0002634', 'abnormal sensorimotor gating', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695598, 'HP:5200044', 'Reduced attention regulation', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695599, 'HP:5200044', 'Reduced attention regulation', 'MP:0003412', 'abnormal afterhyperpolarization', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695600, 'HP:5200044', 'Reduced attention regulation', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695601, 'HP:5200044', 'Reduced attention regulation', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695602, 'HP:5200044', 'Reduced attention regulation', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695603, 'HP:5200044', 'Reduced attention regulation', 'MP:0001912', 'increased cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695604, 'HP:5200044', 'Reduced attention regulation', 'MP:0021015', 'increased tau protein phosphorylation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695605, 'HP:5200044', 'Reduced attention regulation', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695606, 'HP:5200044', 'Reduced attention regulation', 'MP:0003466', 'decreased single cell response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695607, 'HP:5200044', 'Reduced attention regulation', 'MP:0021010', 'impaired synaptic physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695608, 'HP:5200044', 'Reduced attention regulation', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695609, 'HP:5200044', 'Reduced attention regulation', 'MP:0001752', 'abnormal hypothalamus secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695610, 'HP:5200044', 'Reduced attention regulation', 'MP:0004513', 'avnosmia', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695611, 'HP:5200044', 'Reduced attention regulation', 'MP:0003464', 'abnormal single cell response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695612, 'HP:5200044', 'Reduced attention regulation', 'MP:0005403', 'abnormal nerve conduction', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695613, 'HP:5200044', 'Reduced attention regulation', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695614, 'HP:5200044', 'Reduced attention regulation', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695615, 'HP:5200044', 'Reduced attention regulation', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695616, 'HP:5200044', 'Reduced attention regulation', 'MP:0003470', 'abnormal summary potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695617, 'HP:5200044', 'Reduced attention regulation', 'MP:0012011', 'febrile seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695618, 'HP:5200044', 'Reduced attention regulation', 'MP:0011994', 'increased nerve conduction velocity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695619, 'HP:5200044', 'Reduced attention regulation', 'MP:0011397', 'endoneurial edema', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695620, 'HP:5200044', 'Reduced attention regulation', 'MP:0003477', 'abnormal nerve fiber response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695621, 'HP:5200044', 'Reduced attention regulation', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695622, 'HP:5200044', 'Reduced attention regulation', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695623, 'HP:5200044', 'Reduced attention regulation', 'MP:0003463', 'abnormal single cell response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695624, 'HP:5200044', 'Reduced attention regulation', 'MP:0000947', 'convulsive seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695625, 'HP:5200044', 'Reduced attention regulation', 'MP:0003635', 'abnormal synaptic transmission', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695626, 'HP:5200044', 'Reduced attention regulation', 'MP:0003469', 'decreased single cell response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695627, 'HP:5200044', 'Reduced attention regulation', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695628, 'HP:5200044', 'Reduced attention regulation', 'MP:0006080', 'brain ischemia', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695629, 'HP:5200044', 'Reduced attention regulation', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695630, 'HP:5200044', 'Reduced attention regulation', 'MP:0003633', 'abnormal nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695631, 'HP:5200044', 'Reduced attention regulation', 'MP:0002635', 'reduced sensorimotor gating', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695632, 'HP:5200044', 'Reduced attention regulation', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695633, 'HP:5200044', 'Reduced attention regulation', 'MP:0003997', 'tonic-clonic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695634, 'HP:5200044', 'Reduced attention regulation', 'MP:0003473', 'decreased summary potential threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(695635, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0013707', 'abnormal hematopoietic precursor cell morphology', 0.43243243243243246, 7.94655706237675, 1.853739194155074, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(695636, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0010175', 'leptocytosis', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695637, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0005642', 'decreased mean corpuscular hemoglobin concentration', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695638, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0010067', 'increased red blood cell distribution width', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695639, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0012397', 'abnormal nucleated erythrocyte cell number', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695640, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0004230', 'abnormal embryonic erythrocyte morphology', 0.4090909090909091, 10.15319077934013, 2.03803288641123, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(695641, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0009840', 'abnormal foam cell morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(695642, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0011180', 'abnormal hematopoietic cell number', 0.41025641025641024, 7.94655706237675, 1.8055818935480081, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(695643, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0012381', 'increased erythrocyte sodium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695644, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0000358', 'abnormal cell morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(695645, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0012374', 'decreased erythrocyte magnesium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695646, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0013656', 'abnormal hematopoietic cell morphology', 0.45714285714285713, 7.94655706237675, 1.9059674183846, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(695647, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0002596', 'abnormal hematocrit', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695648, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0010177', 'acanthocytosis', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695649, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0009395', 'increased nucleated erythrocyte cell number', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695650, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0009568', 'abnormal red blood cell deformability', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695651, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0002447', 'abnormal erythrocyte morphology', 0.4318181818181818, 10.352905980535489, 2.114372965455578, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695652, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0012375', 'increased erythrocyte magnesium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695653, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0002642', 'anisocytosis', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695654, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0002814', 'hyperchromasia', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695655, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0013661', 'abnormal myeloid cell number', 0.40476190476190477, 9.052558416233639, 1.9141919411394301, 'UPHENO:0085068', 'abnormal myeloid cell morphology'),
(695656, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0010176', 'dacryocytosis', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695657, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0002608', 'increased hematocrit', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695658, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0012378', 'increased erythrocyte potassium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695659, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0012379', 'abnormal erythrocyte sodium ion content', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695660, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0012380', 'decreased erythrocyte sodium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695661, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0012373', 'abnormal erythrocyte magnesium ion content', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695662, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0012377', 'decreased erythrocyte potassium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695663, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0002424', 'abnormal reticulocyte morphology', 0.45, 10.15319077934013, 2.1375069241298514, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(695664, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0012398', 'decreased nucleated erythrocyte cell number', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695665, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0005641', 'increased mean corpuscular hemoglobin concentration', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695666, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0001588', 'abnormal hemoglobin', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695667, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0012376', 'abnormal erythrocyte potassium ion content', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695668, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0012372', 'abnormal erythrocyte ion content', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695669, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0003902', 'abnormal cell mass', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(695670, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0002877', 'abnormal melanocyte morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(695671, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0013657', 'abnormal blood cell morphology', 0.41025641025641024, 7.94655706237675, 1.8055818935480081, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(695672, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0005640', 'abnormal mean corpuscular hemoglobin concentration', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695673, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0010178', 'increased number of Howell-Jolly bodies', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695674, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0011171', 'increased number of Heinz bodies', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695675, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0010066', 'abnormal red blood cell distribution width', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695676, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0010068', 'decreased red blood cell distribution width', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695677, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0010074', 'stomatocytosis', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695678, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0009547', 'elliptocytosis', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695679, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0005097', 'polychromatophilia', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695680, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0013658', 'abnormal myeloid cell morphology', 0.4722222222222222, 9.052558416233639, 2.0675636029177746, 'UPHENO:0085068', 'abnormal myeloid cell morphology'),
(695681, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0013659', 'abnormal erythroid lineage cell morphology', 0.47368421052631576, 10.15319077934013, 2.1930358315893517, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(695682, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0010696', 'increased siderocyte number', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(695683, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0013702', 'abnormal megakaryocyte-erythroid progenitor cell morphology', 0.425, 9.052558416233639, 1.9614630577452374, 'UPHENO:0085068', 'abnormal myeloid cell morphology'),
(695684, 'HP:0033281', 'Circulating nucleated red blood cells', 'MP:0004808', 'abnormal hematopoietic stem cell morphology', 0.41025641025641024, 7.94655706237675, 1.8055818935480081, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(695685, 'HP:0007925', 'Lacrimal duct aplasia', 'MP:0013451', 'nasolacrimal duct obstruction', 0.43103448275862066, 12.607147267911277, 2.3311188733494257, 'UPHENO:0076731', 'abnormal lacrimal drainage system morphology'),
(695686, 'HP:0007925', 'Lacrimal duct aplasia', 'MP:0008968', 'abnormal lacrimal apparatus morphology', 0.40384615384615385, 11.799792345853673, 2.1829568834624955, 'UPHENO:0088074', 'abnormal lacrimal apparatus morphology'),
(695687, 'HP:0007925', 'Lacrimal duct aplasia', 'MP:0008969', 'abnormal nasolacrimal duct morphology', 0.4074074074074074, 12.607147267911277, 2.2663285691230017, 'UPHENO:0076731', 'abnormal lacrimal drainage system morphology'),
(695688, 'HP:0010294', 'Palate fistula', 'MP:0021164', 'oral cleft', 0.40816326530612246, 7.503859459499253, 1.7500856491576207, 'UPHENO:0076800', 'abnormal mouth morphology'),
(695689, 'HP:0010294', 'Palate fistula', 'MP:0013818', 'abnormal oral cavity morphology', 0.42857142857142855, 9.27922043240247, 1.9941937610833897, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(695690, 'HP:0010294', 'Palate fistula', 'MP:0013550', 'abnormal secondary palate morphology', 0.45098039215686275, 11.136827333131242, 2.2410914211782607, 'UPHENO:0076760', 'abnormal secondary palate morphology'),
(695691, 'HP:0010294', 'Palate fistula', 'MP:0021209', 'non-midline cleft palate', 0.40384615384615385, 10.397693902282326, 2.0491629245392673, 'UPHENO:0086824', 'abnormal roof of mouth morphology'),
(695692, 'HP:0010294', 'Palate fistula', 'MP:0009654', 'abnormal primary palate development', 0.40384615384615385, 10.397693902282326, 2.0491629245392673, 'UPHENO:0086824', 'abnormal roof of mouth morphology'),
(695693, 'HP:0010294', 'Palate fistula', 'MP:0003755', 'abnormal palate morphology', 0.42857142857142855, 10.397693902282326, 2.1109605703445924, 'UPHENO:0086824', 'abnormal roof of mouth morphology'),
(695694, 'HP:0010294', 'Palate fistula', 'MP:0030606', 'abnormal gingival sulcus moprhology', 0.4117647058823529, 9.27922043240247, 1.9547008651365874, 'UPHENO:0076786', 'abnormal oral cavity morphology'),
(695695, 'HP:0010294', 'Palate fistula', 'MP:0021213', 'complete cleft palate', 0.40384615384615385, 10.397693902282326, 2.0491629245392673, 'UPHENO:0086824', 'abnormal roof of mouth morphology'),
(695696, 'HP:0010294', 'Palate fistula', 'MP:0009652', 'abnormal palatal rugae morphology', 0.40350877192982454, 11.136827333131242, 2.119860259636538, 'UPHENO:0076760', 'abnormal secondary palate morphology'),
(695697, 'HP:0010294', 'Palate fistula', 'MP:0009653', 'abnormal palate development', 0.4117647058823529, 10.397693902282326, 2.069155231375359, 'UPHENO:0086824', 'abnormal roof of mouth morphology'),
(695698, 'HP:0010294', 'Palate fistula', 'MP:0021214', 'anterior cleft palate', 0.40384615384615385, 10.397693902282326, 2.0491629245392673, 'UPHENO:0086824', 'abnormal roof of mouth morphology'),
(695699, 'HP:0010294', 'Palate fistula', 'MP:0003756', 'abnormal hard palate morphology', 0.4339622641509434, 11.136827333131242, 2.1984000557095484, 'UPHENO:0076760', 'abnormal secondary palate morphology'),
(695700, 'HP:0010294', 'Palate fistula', 'MP:0009655', 'abnormal secondary palate development', 0.40384615384615385, 10.397693902282326, 2.0491629245392673, 'UPHENO:0086824', 'abnormal roof of mouth morphology'),
(695701, 'HP:0010294', 'Palate fistula', 'MP:0000452', 'abnormal mouth morphology', 0.4166666666666667, 7.503859459499253, 1.7682217361305932, 'UPHENO:0076800', 'abnormal mouth morphology'),
(695702, 'HP:0010294', 'Palate fistula', 'MP:0021208', 'median cleft palate', 0.40384615384615385, 10.397693902282326, 2.0491629245392673, 'UPHENO:0086824', 'abnormal roof of mouth morphology'),
(695703, 'HP:0010294', 'Palate fistula', 'MP:0021216', 'abnormal palatal mesenchymal cell differentiation', 0.40384615384615385, 10.397693902282326, 2.0491629245392673, 'UPHENO:0086824', 'abnormal roof of mouth morphology'),
(695704, 'HP:0010294', 'Palate fistula', 'MP:0000111', 'cleft palate', 0.4117647058823529, 10.397693902282326, 2.069155231375359, 'UPHENO:0086824', 'abnormal roof of mouth morphology'),
(695705, 'HP:0010294', 'Palate fistula', 'MP:0021212', 'abnormal primary and secondary palatal fusion', 0.40384615384615385, 10.397693902282326, 2.0491629245392673, 'UPHENO:0086824', 'abnormal roof of mouth morphology'),
(695706, 'HP:0010294', 'Palate fistula', 'MP:0021215', 'abnormal palatal mesenchymal cell proliferation', 0.40384615384615385, 10.397693902282326, 2.0491629245392673, 'UPHENO:0086824', 'abnormal roof of mouth morphology'),
(695707, 'HP:0010294', 'Palate fistula', 'MP:0003154', 'abnormal soft palate morphology', 0.4339622641509434, 11.136827333131242, 2.1984000557095484, 'UPHENO:0076760', 'abnormal secondary palate morphology'),
(695708, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020960', 'increased c-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695709, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012153', 'increased b-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695710, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0008144', 'nyctalopia', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695711, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012037', 'abnormal b-wave latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695712, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0005260', 'ocular hypotension', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695713, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0006251', 'eyelid apraxia', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695714, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0005257', 'abnormal intraocular pressure', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695715, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020958', 'abnormal c-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695716, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0006190', 'retina ischemia', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695717, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0008793', 'abnormal lens epithelium apoptosis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695718, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012143', 'decreased a-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695719, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020977', 'decreased FO-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695720, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0011275', 'abnormal behavioral response to light', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695721, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012036', 'abnormal a-wave latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695722, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020219', 'increased tear production', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695723, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012149', 'decreased b-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695724, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0008795', 'abnormal lens fiber apoptosis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695725, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0008145', 'hemeralopia', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695726, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0005515', 'uveitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695727, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695728, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012035', 'abnormal b-wave shape', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695729, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0002090', 'abnormal vision', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695730, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020980', 'increased FO-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695731, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0014157', 'alacrima', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695732, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020439', 'absent b-wave', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695733, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020860', 'abnormal cornea physiology', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695734, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0003665', 'endophthalmitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695735, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0003096', 'increased corneal light-scattering', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695736, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020978', 'abnormal FO-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695737, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0004022', 'abnormal cone electrophysiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695738, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012031', 'abnormal b-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695739, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695740, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0006157', 'palsy of the eye', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695741, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020962', 'increased c-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695742, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0003100', 'myopia', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695743, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0001337', 'dry eyes', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695744, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0005551', 'abnormal eye electrophysiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695745, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0013479', 'scleritis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695746, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0001389', 'abnormal eye movement', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695747, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012030', 'abnormal a-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695748, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0011832', 'abnormal visual acuity', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695749, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012151', 'increased a-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695750, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012144', 'decreased b-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695751, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012152', 'decreased a-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695752, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0006072', 'abnormal retina apoptosis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695753, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0004021', 'abnormal rod electrophysiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695754, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012040', 'abnormal c-wave shape', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695755, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020861', 'abnormal corneal wound healing', 0.45, 8.795504987450572, 1.98946657281613, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695756, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0014132', 'abnormal tear film physiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695757, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012154', 'decreased b-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695758, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0003011', 'delayed dark adaptation', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695759, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0010749', 'absent visual evoked potential', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695760, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012148', 'decreased a-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695761, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0006149', 'decreased visual acuity', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695762, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695763, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0006152', 'tunnel vision', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695764, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0006147', 'monocular blindness', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695765, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0010748', 'abnormal visual evoked potential', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695766, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020976', 'increased FO-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695767, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0005253', 'abnormal eye physiology', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695768, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0003101', 'high myopia', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695769, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012147', 'increased a-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695770, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020220', 'decreased tear production', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695771, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0006148', 'binocular blindness', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695772, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0006224', 'oculomotor apraxia', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695773, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0031497', 'increased visual acuity', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695774, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0006145', 'legal blindness', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695775, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0005258', 'ocular hypertension', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695776, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012146', 'increased b-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695777, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0013478', 'corneal limbitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695778, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0002001', 'blindness', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695779, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0001851', 'eye inflammation', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695780, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0006194', 'keratoconjunctivitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695781, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0002638', 'abnormal pupillary reflex', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695782, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0005251', 'blepharitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695783, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0006153', 'hypermetropia', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695784, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012033', 'abnormal ERG implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695785, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012050', 'decreased susceptilbility to retina ischemic injury', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695786, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0006203', 'eye hemorrhage', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695787, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020961', 'abnormal c-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695788, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012034', 'abnormal a-wave shape', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695789, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012150', 'increased b-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695790, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012032', 'abnormal ERG latency', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695791, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012038', 'abnormal a-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695792, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0013468', 'chromodacryorrhea', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695793, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695794, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020979', 'decreased FO-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695795, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012039', 'abnormal b-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695796, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020975', 'abnormal FO-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695797, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0001852', 'conjunctivitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695798, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020218', 'abnormal tear production', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695799, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020959', 'decreased c-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695800, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012049', 'increased susceptilbility to retina ischemic injury', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695801, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012145', 'increased a-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695802, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0001313', 'increased incidence of corneal inflammation', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695803, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020963', 'decreased c-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695804, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020974', 'abnormal FO-wave shape', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695805, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695806, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0001999', 'photosensitivity', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695807, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0013145', 'eye discharge', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695808, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695809, 'HP:0030464', 'Asymmetrical distribution of pattern reversal visual evoked potentials', 'MP:0006150', 'double vision', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(695810, 'HP:0034502', 'Narrow mediastinum', 'MP:0013332', 'peliosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695811, 'HP:0034502', 'Narrow mediastinum', 'MP:0010233', 'hairless tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695812, 'HP:0034502', 'Narrow mediastinum', 'MP:0013113', 'greasy tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695813, 'HP:0034502', 'Narrow mediastinum', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695814, 'HP:0034502', 'Narrow mediastinum', 'MP:0008923', 'thoracoschisis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695815, 'HP:0034502', 'Narrow mediastinum', 'MP:0013118', 'swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695816, 'HP:0034502', 'Narrow mediastinum', 'MP:0031310', 'abnormal cyst', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695817, 'HP:0034502', 'Narrow mediastinum', 'MP:0003279', 'aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695818, 'HP:0034502', 'Narrow mediastinum', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695819, 'HP:0034502', 'Narrow mediastinum', 'MP:0004134', 'abnormal chest morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695820, 'HP:0034502', 'Narrow mediastinum', 'MP:0005508', 'abnormal skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695821, 'HP:0034502', 'Narrow mediastinum', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695822, 'HP:0034502', 'Narrow mediastinum', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695823, 'HP:0034502', 'Narrow mediastinum', 'MP:0002132', 'abnormal respiratory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695824, 'HP:0034502', 'Narrow mediastinum', 'MP:0000685', 'abnormal immune system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695825, 'HP:0034502', 'Narrow mediastinum', 'MP:0002160', 'abnormal reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695826, 'HP:0034502', 'Narrow mediastinum', 'MP:0014134', 'abnormal embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695827, 'HP:0034502', 'Narrow mediastinum', 'MP:0005500', 'abnormal gustatory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695828, 'HP:0034502', 'Narrow mediastinum', 'MP:0004733', 'abnormal thoracic cavity morphology', 0.4166666666666667, 14.384754846574829, 2.4481927727896577, 'UPHENO:0075866', 'abnormal thoracic cavity'),
(695829, 'HP:0034502', 'Narrow mediastinum', 'MP:0002925', 'abnormal cardiovascular development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695830, 'HP:0034502', 'Narrow mediastinum', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695831, 'HP:0034502', 'Narrow mediastinum', 'MP:0002163', 'abnormal gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695832, 'HP:0034502', 'Narrow mediastinum', 'MP:0005499', 'abnormal olfactory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695833, 'HP:0034502', 'Narrow mediastinum', 'MP:0002108', 'abnormal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695834, 'HP:0034502', 'Narrow mediastinum', 'MP:0002109', 'abnormal limb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695835, 'HP:0034502', 'Narrow mediastinum', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695836, 'HP:0034502', 'Narrow mediastinum', 'MP:0003632', 'abnormal nervous system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695837, 'HP:0034502', 'Narrow mediastinum', 'MP:0003385', 'abnormal body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695838, 'HP:0034502', 'Narrow mediastinum', 'MP:0020982', 'abnormal skin adnexa development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695839, 'HP:0034502', 'Narrow mediastinum', 'MP:0002111', 'abnormal tail morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695840, 'HP:0034502', 'Narrow mediastinum', 'MP:0000428', 'abnormal craniofacial morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695841, 'HP:0034502', 'Narrow mediastinum', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695842, 'HP:0034502', 'Narrow mediastinum', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695843, 'HP:0034502', 'Narrow mediastinum', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695844, 'HP:0034502', 'Narrow mediastinum', 'MP:0020973', 'abnormal gland development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695845, 'HP:0034502', 'Narrow mediastinum', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695846, 'HP:0034502', 'Narrow mediastinum', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695847, 'HP:0034502', 'Narrow mediastinum', 'MP:0006281', 'abnormal tail development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695848, 'HP:0034502', 'Narrow mediastinum', 'MP:0000462', 'abnormal digestive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(695849, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695850, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008403', 'decreased cellular sensitivity to alkylating agents', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695851, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0010951', 'abnormal lipid oxidation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695852, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695853, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0004966', 'abnormal inner cell mass proliferation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695854, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695855, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0013503', 'abnormal embryonic tissue cell apoptosis', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695856, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0010095', 'increased chromosomal stability', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695857, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0004185', 'abnormal adipocyte glucose uptake', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695858, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008008', 'early cellular replicative senescence', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695859, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0004759', 'decreased mitotic index', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695860, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695861, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008407', 'decreased cellular sensitivity to hydrogen peroxide', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695862, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0011825', 'decreased cell chemotaxis', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695863, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0004130', 'abnormal muscle cell glucose uptake', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695864, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0013500', 'abnormal fibroblast apoptosis', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695865, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0010094', 'abnormal chromosome stability', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695866, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0002007', 'increased cellular sensitivity to gamma-irradiation', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695867, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003123', 'paternal imprinting', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695868, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0014240', 'abnormal ribosome physiology', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695869, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008866', 'chromosomal instability', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695870, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0030909', 'abnormal melanocyte adhesion', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695871, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0001648', 'abnormal apoptosis', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695872, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695873, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0010954', 'abnormal cellular respiration', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695874, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0012115', 'abnormal trophectoderm cell proliferation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695875, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0011804', 'increased cell migration', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695876, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0012201', 'decreased endothelial cell proliferation', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695877, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0020845', 'abnormal DNA-templated transcription', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695878, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0010957', 'abnormal aerobic respiration', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695879, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695880, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0000313', 'abnormal cell death', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695881, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0030904', 'abnormal melanoblast physiology', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695882, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695883, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003186', 'abnormal redox activity', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695884, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695885, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695886, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0011702', 'abnormal fibroblast proliferation', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695887, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003207', 'decreased cellular sensitivity to gamma-irradiation', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695888, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0011805', 'decreased cell migration', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695889, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695890, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0004811', 'abnormal neuron physiology', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695891, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008009', 'delayed cellular replicative senescence', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695892, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0020363', 'abnormal germ cell physiology', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695893, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0012241', 'abnormal hepatoblast physiology', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695894, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0001819', 'abnormal immune cell physiology', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695895, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003656', 'abnormal erythrocyte physiology', 0.42105263157894735, 9.120647406075808, 1.9596613462616235, 'UPHENO:0085189', 'abnormal blood cell'),
(695896, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0030938', 'abnormal reticulophagy', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695897, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0000351', 'increased cell proliferation', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695898, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003566', 'abnormal cell adhesion', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695899, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0010741', 'abnormal melanocyte proliferation', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695900, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0011706', 'abnormal fibroblast migration', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695901, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0013210', 'abnormal primary cilium physiology', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695902, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008942', 'abnormal induced cell death', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695903, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0000316', 'cellular necrosis', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695904, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0010680', 'abnormal skin adnexa physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695905, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003926', 'decreased cellular glucose uptake', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695906, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0011810', 'increased anoikis', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695907, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695908, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695909, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0010034', 'abnormal erythrocyte clearance', 0.41025641025641024, 9.120647406075808, 1.934374333998231, 'UPHENO:0085189', 'abnormal blood cell'),
(695910, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008877', 'abnormal DNA methylation', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695911, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0009410', 'abnormal skeletal muscle satellite cell proliferation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695912, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695913, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0014241', 'abnormal intracellular organelle physiology', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695914, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0020426', 'abnormal beige fat cell physiology', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695915, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0031471', 'abnormal micropinocytosis', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695916, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695917, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0020848', 'abnormal exocytosis', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695918, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0020414', 'abnormal fibroblast physiology', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695919, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0012746', 'abnormal neural crest cell delamination', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695920, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0009876', 'increased cellular sensitivity to thiophosphamide', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695921, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0000352', 'decreased cell proliferation', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695922, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0012382', 'abnormal blood cell physiology', 0.43333333333333335, 5.816527256141925, 1.5876067347829461, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(695923, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0006043', 'decreased apoptosis', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695924, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0009842', 'abnormal neural crest cell proliferation', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695925, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0002879', 'increased cellular sensitivity to X-ray irradiation', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695926, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0010163', 'hemolysis', 0.41025641025641024, 9.120647406075808, 1.934374333998231, 'UPHENO:0085189', 'abnormal blood cell'),
(695927, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0001985', 'abnormal gustatory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695928, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003091', 'abnormal cell migration', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695929, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0011809', 'abnormal anoikis', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695930, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4482758620689655, 5.816527256141925, 1.6147472774383786, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(695931, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0002164', 'abnormal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695932, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008260', 'abnormal autophagy', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695933, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695934, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0010763', 'abnormal hematopoietic stem cell physiology', 0.45454545454545453, 7.733703155395898, 1.8749185625218618, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695935, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0031126', 'gangrene', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695936, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0002429', 'abnormal blood cell morphology/development', 0.40625, 9.120647406075808, 1.9249059739941317, 'UPHENO:0085189', 'abnormal blood cell'),
(695937, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0012555', 'decreased cell death', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695938, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695939, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695940, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0011824', 'increased cell chemotaxis', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695941, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0004046', 'abnormal mitosis', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695942, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0030941', 'enhanced autophagy', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695943, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008408', 'decreased cellular sensitivity to hydroxyurea', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695944, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0004587', 'decreased cellular sensitivity to X-ray irradiation', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695945, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0011811', 'decreased anoikis', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695946, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008404', 'increased cellular sensitivity to methylmethanesulfonate', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695947, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003927', 'increased cellular glucose import', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695948, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0031127', 'dry gangrene', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695949, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0005621', 'abnormal cell physiology', 0.5, 7.733703155395898, 1.96643117797139, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695950, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0011255', 'abnormal anterior visceral endoderm cell migration', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695951, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0014043', 'decreased cellular sensitivity to cisplatin', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695952, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0020846', 'abnormal cell motility', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695953, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008409', 'increased cellular sensitivity to hydroxyurea', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695954, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003172', 'abnormal lysosome physiology', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695955, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0031470', 'abnormal macropinocytosis', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695956, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695957, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695958, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695959, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0013209', 'abnormal motile cilium physiology', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695960, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0009567', 'mitotic nondisjunction', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695961, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0013208', 'abnormal cilium physiology', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695962, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0012556', 'increased cell death', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695963, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0006042', 'increased apoptosis', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695964, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0006298', 'abnormal platelet activation', 0.4090909090909091, 12.700256672302759, 2.2793770086934324, 'UPHENO:0085600', 'abnormality of platelet physiology'),
(695965, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0011518', 'abnormal cell chemotaxis', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695966, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0020352', 'abnormal endoplasmic reticulum physiology', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695967, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003787', 'abnormal imprinting', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695968, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0005076', 'abnormal cell differentiation', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695969, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0031469', 'abnormal pinocytosis', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695970, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003122', 'maternal imprinting', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695971, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0000350', 'abnormal cell proliferation', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695972, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008402', 'increased cellular sensitivity to alkylating agents', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695973, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0020847', 'abnormal peroxisome physiology', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695974, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003077', 'abnormal cell cycle', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695975, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008943', 'increased sensitivity to induced cell death', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695976, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695977, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0012745', 'abnormal neural crest cell physiology', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695978, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0014041', 'increased cellular sensitivity to cisplatin', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695979, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003192', 'increased cholesterol efflux', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695980, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008406', 'increased cellular sensitivity to hydrogen peroxide', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695981, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0012197', 'impaired myofibroblast differentiation', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695982, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0012200', 'increased endothelial cell proliferation', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695983, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695984, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008405', 'decreased cellular sensitivity to methylmethanesulfonate', 0.4117647058823529, 7.733703155395898, 1.7845072163381734, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695985, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0030951', 'abnormal endocytosis', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695986, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0010381', 'abnormal dosage compensation', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695987, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0014046', 'abnormal mitophagy', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695988, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0004760', 'increased mitotic index', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695989, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003193', 'decreased cholesterol efflux', 0.42424242424242425, 7.733703155395898, 1.8113434171952159, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695990, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695991, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008007', 'abnormal cellular replicative senescence', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695992, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0001983', 'abnormal olfactory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(695993, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695994, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.45161290322580644, 7.733703155395898, 1.8688606514919515, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695995, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0005464', 'abnormal platelet physiology', 0.4186046511627907, 12.700256672302759, 2.305729063438981, 'UPHENO:0085600', 'abnormality of platelet physiology'),
(695996, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0030940', 'impaired autophagy', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695997, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0030939', 'abnormal autophagosome formation', 0.4375, 7.733703155395898, 1.8394279356598087, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695998, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4827586206896552, 7.733703155395898, 1.932229765872102, 'UPHENO:0085578', 'abnormality of cell physiology'),
(695999, 'HP:0030396', 'Abnormal platelet granule secretion', 'MP:0003674', 'oxidative stress', 0.4666666666666667, 7.733703155395898, 1.8997530030291006, 'UPHENO:0085578', 'abnormality of cell physiology'),
(696000, 'HP:0004696', 'Talipes cavus equinovarus', 'MP:0030881', 'abnormal knee morphology', 0.4375, 7.553673854641961, 1.8178922716722952, 'UPHENO:0003070', 'abnormal leg'),
(696001, 'HP:0004696', 'Talipes cavus equinovarus', 'MP:0003857', 'abnormal hindlimb zeugopod morphology', 0.4375, 7.553673854641961, 1.8178922716722952, 'UPHENO:0003070', 'abnormal leg'),
(696002, 'HP:0004696', 'Talipes cavus equinovarus', 'MP:0002109', 'abnormal limb morphology', 0.42857142857142855, 5.844765229200882, 1.5826873929943446, 'UPHENO:0086635', 'abnormal limb morphology'),
(696003, 'HP:0004696', 'Talipes cavus equinovarus', 'MP:0006279', 'abnormal limb development', 0.41379310344827586, 5.844765229200882, 1.5551602949913577, 'UPHENO:0086635', 'abnormal limb morphology'),
(696004, 'HP:0004696', 'Talipes cavus equinovarus', 'MP:0002110', 'abnormal digit morphology', 0.40625, 6.296534486251748, 1.59936460353472, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(696005, 'HP:0004696', 'Talipes cavus equinovarus', 'MP:0031291', 'pes valgus', 0.43333333333333335, 6.296534486251748, 1.6518166597342931, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(696006, 'HP:0004696', 'Talipes cavus equinovarus', 'MP:0008909', 'supination', 0.43333333333333335, 6.296534486251748, 1.6518166597342931, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(696007, 'HP:0004696', 'Talipes cavus equinovarus', 'MP:0009049', 'abnormal hallux morphology', 0.4166666666666667, 7.503859459499253, 1.7682217361305932, 'UPHENO:0081575', 'abnormal pes morphology'),
(696008, 'HP:0004696', 'Talipes cavus equinovarus', 'MP:0000578', 'ulcerated paws', 0.43333333333333335, 6.296534486251748, 1.6518166597342931, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(696009, 'HP:0004696', 'Talipes cavus equinovarus', 'MP:0003856', 'abnormal hindlimb stylopod morphology', 0.45161290322580644, 7.553673854641961, 1.8469803950003705, 'UPHENO:0003070', 'abnormal leg'),
(696010, 'HP:0004696', 'Talipes cavus equinovarus', 'MP:0000556', 'abnormal hindlimb morphology', 0.4482758620689655, 7.109295430960158, 1.7851962183515353, 'UPHENO:0086628', 'abnormal hindlimb morphology'),
(696011, 'HP:0004696', 'Talipes cavus equinovarus', 'MP:0000572', 'abnormal autopod morphology', 0.4482758620689655, 6.296534486251748, 1.6800548874579881, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(696012, 'HP:0004696', 'Talipes cavus equinovarus', 'MP:0013133', 'pale limbs', 0.41379310344827586, 5.844765229200882, 1.5551602949913577, 'UPHENO:0086635', 'abnormal limb morphology'),
(696013, 'HP:0004696', 'Talipes cavus equinovarus', 'MP:0013076', 'autopod wound', 0.40625, 6.296534486251748, 1.59936460353472, 'UPHENO:0087006', 'abnormal autopod region morphology'),
(696014, 'HP:0012813', 'Unilateral breast hypoplasia', 'MP:0000071', 'axial skeleton hypoplasia', 0.46808510638297873, 8.202005804774931, 1.9593970398267633, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(696015, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696016, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696017, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696018, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696019, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696020, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696021, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696022, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696023, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696024, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696025, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696026, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696027, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696028, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696029, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696030, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696031, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696032, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696033, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696034, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696035, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696036, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696037, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696038, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696039, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696040, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696041, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696042, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696043, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696044, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696045, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696046, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696047, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696048, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696049, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696050, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696051, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696052, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696053, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696054, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696055, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696056, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696057, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696058, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696059, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696060, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696061, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696062, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696063, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696064, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696065, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696066, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696067, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696068, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696069, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696070, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696071, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696072, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696073, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696074, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696075, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696076, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696077, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696078, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696079, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696080, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696081, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696082, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696083, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696084, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696085, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696086, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696087, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696088, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696089, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696090, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696091, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696092, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696093, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696094, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696095, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696096, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696097, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696098, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696099, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696100, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696101, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696102, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696103, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696104, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696105, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696106, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696107, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696108, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696109, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696110, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696111, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696112, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696113, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696114, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696115, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696116, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696117, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696118, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696119, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696120, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696121, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696122, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696123, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696124, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696125, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696126, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696127, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696128, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696129, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696130, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696131, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696132, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696133, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696134, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696135, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696136, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696137, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696138, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696139, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696140, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696141, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696142, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696143, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696144, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696145, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696146, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696147, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696148, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696149, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696150, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696151, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696152, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696153, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696154, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696155, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696156, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696157, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696158, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696159, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696160, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696161, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696162, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696163, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696164, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696165, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696166, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696167, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696168, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696169, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696170, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696171, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696172, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696173, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696174, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696175, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696176, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696177, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696178, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696179, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696180, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696181, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696182, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696183, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696184, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696185, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696186, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696187, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696188, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696189, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696190, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696191, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696192, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696193, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696194, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696195, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696196, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696197, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696198, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696199, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696200, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696201, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696202, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696203, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696204, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696205, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696206, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696207, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696208, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696209, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696210, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696211, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696212, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696213, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696214, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696215, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696216, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696217, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696218, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696219, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696220, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696221, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696222, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696223, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696224, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696225, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696226, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696227, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696228, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696229, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696230, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696231, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696232, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696233, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696234, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696235, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696236, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696237, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696238, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696239, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696240, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696241, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696242, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696243, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696244, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696245, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696246, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696247, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696248, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696249, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696250, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696251, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696252, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696253, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696254, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696255, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696256, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696257, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696258, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696259, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696260, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696261, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696262, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696263, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696264, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696265, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696266, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696267, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696268, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696269, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696270, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696271, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696272, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696273, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696274, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696275, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696276, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696277, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696278, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696279, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696280, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696281, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696282, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696283, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696284, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696285, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696286, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696287, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696288, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696289, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696290, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696291, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696292, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696293, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696294, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696295, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696296, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696297, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696298, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696299, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696300, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696301, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696302, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696303, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696304, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696305, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696306, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696307, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696308, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(696309, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696310, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696311, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696312, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696313, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(696314, 'HP:0034111', 'Anti-MIT3 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
